RRGB's cost discipline and "First Choice" strategy are lifting margins and fueling EBITDA growth despite traffic declines.

AbbVie edges past Merck in 2025 as strong Skyrizi and Rinvoq sales, pipeline gains and rising estimates fuel growth momentum.

QS is advancing from lab work to real-world testing as B1 shipments aim to set up 2026 road trials for its solid-state batteries.

New digital tools from URI improve jobsite planning and rental efficiency.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PubMatic To Contact Him Directly To Discuss Their Options

Alibaba Group (NYSE:BABA)'s NYSE-listed shares climbed about 12% to $133.85 in early Friday trading after Chinese e-commerce and cloud-computing company reported better-than-expected earnings and stronger cloud growth for its first-quarter 2025. Alibaba saw its adjusted earnings per share for the period fall 10% to 14.75 yuan, although it surpassed the 14.16-yuan analyst consensus forecast, according to FactSet.

Sagimet Biosciences offers a unique play in MASH with Denifanstat, a FASN inhibitor showing both fat reduction and fibrosis regression in Phase 2b. The FDA's acceptance of non-invasive trial endpoints accelerates Sagimet's Phase 3 timeline, lowering barriers and costs for approval. Despite recent gains, Sagimet's valuation remains attractive, supported by a strong cash position and significant market opportunity if Phase 3 succeeds.

TORONTO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Ontario's five largest REALTOR® associations, representing more than 90 per cent of the nearly 100,000 REALTORS® in the province, support the Ford government's decision to intervene in the review of the Real Estate Council of Ontario (RECO) following the iPro Realty Ltd. investigation.

Artificial intelligence-related products led Alibaba Group's gains during a quarter in which the global technology company earned double-digit year-over-year revenue growth across its businesses.

SYF is growing its CareCredit network in Health & Wellness, tapping resilient demand to power long-term expansion.

SHEL deepens its commitment to Nigeria's energy sector as the Temis Flotel joins Bonga's maintenance drive, ensuring safe and efficient offshore operations.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), of the important September 16, 2025 lead plaintiff deadline.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in RxSight between November 7, 2024 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. ("RxSight" or …

Dick's Sporting Goods is a well-run retailer with strong financials and impressive returns under current leadership, but faces macroeconomic and valuation risks. The Foot Locker acquisition is unlikely to be accretive to earnings in the near term, making the deal a bet on management's turnaround ability. While organic growth drivers like GameChanger and new store concepts offer upside, expectations for sustained double-digit growth may be optimistic.

Dell Technologies Inc (NASDAQ:DELL) shares fell after the company posted record second quarter results but reported margin pressure and issued adjusted earnings guidance below Wall Street expectations. For the fiscal second quarter ended August 2, 2025, Dell reported revenue of $29.8 billion, up 19% from a year earlier, and adjusted earnings per share of $2.32, a 19% increase.

OPEN is shifting to an agent-led platform with new selling options, aiming for higher conversions and leaner, margin-friendly growth.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Replimune between November 22, 2024 and July 21, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. ("Replimune" …

GPRE will sell its Tennessee ethanol plant for $190 million, using proceeds to cut debt and advance the carbon strategy.

Victoria's Secret & Co. shows weak U.S. performance and muted overall growth, with international markets providing the only bright spot in recent results. Margins are under pressure from tariffs and higher costs, and the company expects lower profitability and free cash flow for the rest of FY25. Valuation is now more reasonable after a significant stock decline, but ongoing execution concerns and a lack of insider buying keep me cautious.

3M's Q2 showed strong cash conversion, disciplined margins, and resilient operations, but top-line growth remains modest amid ongoing litigation overhang. Recent litigation developments, including PFAS case progress and strategic asset sales, incrementally de-risk 3M and support a gradual rerating of its valuation. Segment outlooks are steady: Safety & Industrial and Consumer show stable growth and margin recovery, while Transport & Electronics remains cyclically challenged near-term.